|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
7K99CA158065-02
|
$100,961
|
$100,961
|
Rink, Lori
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zbtb family members in lymphocyte differentiation and function
|
ZIA BC 011429
|
$402,116
|
$402,116
|
Kovalovsky, Damian
|
CCR (NCI)
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$707,692
|
$530,769
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$707,692
|
$424,615
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$102,440
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-11
|
$7,000
|
$1,050
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-22
|
$1,669,985
|
$333,997
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Initiative Cancer Survivor Cohort
|
1UM1CA173642-01
|
$1,894,768
|
$341,058
|
ANDERSON, GARNET
|
FRED HUTCHINSON CAN RES CTR
|
|
Wnt Signaling in Colon Cancer
|
5R01CA108697-08
|
$269,326
|
$269,326
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$318,862
|
$63,772
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Widespread vs Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
1R21CA167202-01A1
|
$171,825
|
$171,825
|
Hwang, Jessica
|
UT MD ANDERSON CANCER CTR
|
|
WESTERN ONCOLOGY RESEARCH CONSORTIUM
|
5U10CA045377-27
|
$589,569
|
$70,748
|
Conlin, Alison
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri
|
5R01CA140285-04
|
$285,146
|
$285,146
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
Vitamin D Effect on Body Composition During Behavioral Weight Loss in Women
|
5R03CA162482-02
|
$82,720
|
$41,360
|
McTiernan, Anne
|
FRED HUTCHINSON CAN RES CTR
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-05S1
|
$154,236
|
$30,847
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-05
|
$1,849,208
|
$369,842
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Virtual Fly-Over Colonoscopy System for Clinical Test-SBIR Phase 1
|
1R43CA179911-01
|
$148,821
|
$148,821
|
Elshazly, Salwa
|
KENTUCKY IMAGING TECHNOLOGIES, LLC
|
|
Virtual Colonoscopy and Colorectal Cancer Screening
|
5R01CA144835-04
|
$461,082
|
$461,082
|
SMITH, MAUREEN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$73,500
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$10,579
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-25
|
$430,440
|
$142,045
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$17,500
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$60,439
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,345,130
|
$336,283
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vanderbilt Proteome Characterization Center
|
5U24CA159988-03
|
$2,613,578
|
$2,613,578
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY MED CTR
|
|
Vanberbilt Biomarker Developmental Laboratory
|
5U01CA152647-04
|
$584,705
|
$292,353
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY MED CTR
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$265,729
|
$265,729
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
VALIDATION OF THE IPQ-R ADAPTED FOR COLORECTAL CANCER RISK
|
5R21CA164544-02
|
$186,458
|
$186,458
|
DESHPANDE, ANJALI
|
WASHINGTON UNIVERSITY
|
|
Validation of Metabolic Signature Epigenetic Biomarkers for Colon Cancer Risk
|
1R03CA180533-01
|
$77,500
|
$77,500
|
SAPIENZA, CARMEN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
5R01CA154823-03
|
$547,794
|
$547,794
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer
|
2R01CA132829-05
|
$424,662
|
$424,662
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
Validation and commercialization of a/LCI for detection of esophageal neoplasia
|
5R44CA128163-07
|
$912,907
|
$912,907
|
Gebhart, Steven
|
ONCOSCOPE, INC.
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-04
|
$278,654
|
$139,327
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$375,513
|
$37,551
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$375,513
|
$75,103
|
Hodge, James
|
CCR (NCI)
|
|
Using vitamin D glucuronide pro-drugs to prevent/treat colon cancer
|
1R15CA173628-01
|
$435,848
|
$435,848
|
Goff, Jesse
|
IOWA STATE UNIVERSITY
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
7U01CA105492-10
|
$664,043
|
$166,011
|
HOLLAND, ERIC
|
FRED HUTCHINSON CAN RES CTR
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIA BC 010736
|
$215,271
|
$21,527
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
1R01CA176828-01A1
|
$416,716
|
$416,716
|
Goggins, Michael
|
JOHNS HOPKINS UNIVERSITY
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-02
|
$334,999
|
$167,500
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Using evolutionary analysis to prevent virally induced cancer
|
1F31CA180609-01
|
$35,308
|
$35,308
|
Maher, Cyrus
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$523,027
|
$52,303
|
Keefer, Larry
|
CCR (NCI)
|
|
Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
|
5R21CA164449-02
|
$167,603
|
$67,041
|
Guadagnolo, Beverly
|
UT MD ANDERSON CANCER CTR
|
|
Use of Closely Related Inbred Strains to Identify Modifier Loci of Tumorigenesis
|
5R21CA169758-02
|
$158,449
|
$158,449
|
Siracusa, Linda
|
THOMAS JEFFERSON UNIVERSITY
|
|
Use of 2-deoxy-D-glucose & PI3K/Akt pathway inhibitors in head & neck cancer ther
|
5K01CA134941-05
|
$113,750
|
$113,750
|
Burnett, Andrean
|
UNIVERSITY OF IOWA
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
5K07CA160722-03
|
$170,100
|
$170,100
|
Sanoff, Hanna
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$127,800
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
2U54CA096300-11
|
$1,077,820
|
$204,786
|
Lopez-Berestein, Gabriel
|
UT MD ANDERSON CANCER CTR
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
2U54CA096297-11
|
$1,560,830
|
$608,724
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-11S1
|
$307,162
|
$119,793
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
Total relevant funding to Digestive Diseases for this search: $431,405,040
|